Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-4.94%
↓ 100% vs avg
Percentile
P8
Near historical low
Streak
2 qtr
Consecutive declineDecelerating
Average
5264.46%
Historical baseline
PeriodValue
Q4 2025-4.94%
Q3 2025-2.53%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 2023-100.00%
Q2 202368535.62%
Q1 20239.88%
Q4 20220.00%